A 20-patient study showed its ultrasound PAD balloon was effective in patients with arterial blockage below the knee.

Days after the FDA approved Optinose’s nasal polyp drug, its commercialization will be the focus of a post-IPO spending spree.

Israeli diagnostics player MeMed reported data showing its blood test can accurately tell the difference between a bacterial and a viral infection. 

The FDA cleared Medtronic's latest spinal cord stimulation system for the treatment of chronic intractable pain.

The investment brings the total series A haul up to $46 million and equips Cambridge Medical Robotics to build on tests of its device on cadavers.

Rob Brainin jumped ship from Illumina and has been named executive vice president and chief operating officer of the genomics company WuXi NextCODE.

NuVasive's LessRay system for reducing exposure to radiation in hospital operating rooms—and particularly keyhole spinal surgery—has been given the go-…

LivaNova decided to look to offload the $250 million-a-year pacemaker and defibrillator unit after concluding it no longer fits with its strategy.

The Pear Therapeutics app delivers cognitive behavioral therapy to help patients abstain from substance abuse and stay in outpatient programs.